Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling
US FDA wants to work with practitioners to develop suggested prescribing standards, which could then be used to create packaging requirements.
You may also be interested in...
With FDA 'si label comprehension study near completion, sponsors seem more positive about OTC versions of naloxone products. FDA has made clear it is interested in switching the product from Rx-only but had trouble generating sponsor desire to develop it.
Now that US FDA is about to complete label comprehension study, sponsors seem more positive about OTC versions of naloxone products.
Commissioner Gottlieb says US FDA does not intend to force physicians to adhere to opioid prescribing guidelines being developed by National Academies of Sciences, Engineering, and Medicine.